Completed PHASE2 INTERVENTIONAL 2-arm NCT01939171

Thymoglobulin in Cadaver Donor

Conditioning of the Cadaver Donor by Thymoglobulin Administered to Reduce the Pro-inflammatory State After Brain Death.

Sponsor: Hospital de Santa Maria, Portugal

Conditions Prevention of Kidney Injury Associated With Brain Death

Updated 5 times since 2017 Last updated: Sep 5, 2013 Started: Jun 30, 2010 Primary completion: Feb 29, 2012 Completion: Feb 29, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Prevention of Kidney Injury Associated With Brain Death, this trial is completed. The trial is conducted by Hospital de Santa Maria, Portugal and has accumulated 5 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jun 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital de Santa Maria, Portugal
Instituto de Investigación Hospital Universitario La Paz

Data source: Instituto de Investigación Hospital Universitario La Paz

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lisbon, Portugal
• Madrid, Spain